Sundance BioSciences Overview
- Year Founded
-
2025
- Status
-
Private
- Employees
-
13
- Latest Deal Type
-
Early Stage VC
- Investors
-
3
Sundance BioSciences General Information
Description
Developer of oral TYK2 inhibitor therapies designed to treat immune and neuroinflammatory disorders. The company offers brain-penetrant and peripherally restricted TYK2 inhibitors with targeted immune modulation, enabling patients with immune and neuroinflammatory conditions to access potential oral treatment options.
Contact Information
Website
www.sundancebio.comCorporate Office
- 343 Oyster Point Boulevard
- Suite 120
- South San Francisco, CA 94080
- United States
Corporate Office
- 343 Oyster Point Boulevard
- Suite 120
- South San Francisco, CA 94080
- United States
Sundance BioSciences Timeline
Sundance BioSciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 01-Jan-2026 | Completed | Clinical Trials - Phase 1 | |||
| 1. Early Stage VC (Series A) | 30-Jul-2025 | Completed | Generating Revenue |
Sundance BioSciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A2 | ||||||||
| Series A1 |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Sundance BioSciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sundance BioSciences Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Agent Capital | Venture Capital | Minority | ||
| Westlake Village BioPartners | Venture Capital | Minority | ||
| Perceptive Advisors | Venture Capital | Minority |
Sundance BioSciences FAQs
-
When was Sundance BioSciences founded?
Sundance BioSciences was founded in 2025.
-
Where is Sundance BioSciences headquartered?
Sundance BioSciences is headquartered in South San Francisco, CA.
-
What is the size of Sundance BioSciences?
Sundance BioSciences has 13 total employees.
-
What industry is Sundance BioSciences in?
Sundance BioSciences’s primary industry is Drug Discovery.
-
Is Sundance BioSciences a private or public company?
Sundance BioSciences is a Private company.
-
What is Sundance BioSciences’s current revenue?
The current revenue for Sundance BioSciences is .
-
How much funding has Sundance BioSciences raised over time?
Sundance BioSciences has raised $72.7M.
-
Who are Sundance BioSciences’s investors?
Agent Capital, Westlake Village BioPartners, and Perceptive Advisors have invested in Sundance BioSciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
